These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1481055

  • 1. [Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].
    Creutzig A, Caspary L, Alexander K.
    Vasa Suppl; 1992; 35():36-8. PubMed ID: 1481055
    [No Abstract] [Full Text] [Related]

  • 2. [Placebo controlled, double-blind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease].
    Stiegler H, Diehm C, Grom E, Martin M, Mörl H, Rudofsky G, Vogelberg KH.
    Vasa Suppl; 1992; 35():164-6. PubMed ID: 1481031
    [No Abstract] [Full Text] [Related]

  • 3. [Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease].
    Scheffler P, de la Hamette D, Leipnitz G.
    Vasa Suppl; 1991; 33():343-4. PubMed ID: 1788750
    [Abstract] [Full Text] [Related]

  • 4. Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.
    Thum J, Caspary L, Creutzig A, Alexander K.
    Vasa; 1998 May; 27(2):100-5. PubMed ID: 9612114
    [Abstract] [Full Text] [Related]

  • 5. Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
    Creutzig A, Arnold A, Caspary L, Thum J, Alexander K.
    Angiology; 1995 May; 46(5):357-67. PubMed ID: 7741319
    [Abstract] [Full Text] [Related]

  • 6. [Reflex oximetry for evaluating blood redistribution in patients with arterial occlusive disease treated with PGE1].
    Thum J, Caspary L, Creutzig A, Alexander K.
    Vasa Suppl; 1992 May; 35():39-41. PubMed ID: 1481056
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
    Weiss T, Griesshaber J, Rogatti W, Kistner O, Hsu E, Jansen T, Diehm C.
    Vasa Suppl; 1991 May; 33():341-2. PubMed ID: 1788749
    [Abstract] [Full Text] [Related]

  • 8. Skin surface oxygen pressure fields during administration of prostaglandin E1 in patients with arterial occlusive disease.
    Creutzig A, Caspary L, Alexander K.
    Klin Wochenschr; 1990 Feb 15; 68(4):207-12. PubMed ID: 2314008
    [Abstract] [Full Text] [Related]

  • 9. [The reproducibility of transcutaneous oxygen pressure by continuous registration].
    Creutzig A, Caspary L, Alexander K.
    Vasa Suppl; 1992 Feb 15; 35():32-3. PubMed ID: 1481053
    [No Abstract] [Full Text] [Related]

  • 10. [Prostaglandin E1 in intermittent claudication].
    Scheffler P, de la Hamette D, Rogatti W.
    Vasa Suppl; 1992 Feb 15; 35():147-8. PubMed ID: 1481022
    [No Abstract] [Full Text] [Related]

  • 11. [Pilot study of the effect of intravenous prostavasin therapy of inpatients with diabetes mellitus and IIb arterial occlusive disease].
    Rosak C, Hofmann U, König P, Nitsche GB.
    Vasa Suppl; 1991 Feb 15; 33():339-40. PubMed ID: 1788748
    [No Abstract] [Full Text] [Related]

  • 12. [Controlled long-term blood pressure measurement with intravenous prostaglandin E1 infusion].
    Heidrich H, Brodel C, Meuche C, Hellmann M, Ranft J.
    Vasa; 1991 Feb 15; 20(1):13-6. PubMed ID: 2031393
    [Abstract] [Full Text] [Related]

  • 13. [Experience with intravenous prostaglandin E1 in stage II b arterial occlusive disease].
    Dé P, Hepp W.
    Vasa Suppl; 1990 Feb 15; 30():139-41. PubMed ID: 2075565
    [No Abstract] [Full Text] [Related]

  • 14. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
    Rudofsky G.
    Vasa Suppl; 1988 Feb 15; 23():121-5. PubMed ID: 3206330
    [No Abstract] [Full Text] [Related]

  • 15. [Long-term blood pressure measurements with i.v. prostaglandin E1 infusion].
    Heidrich H, Brodel C, Meuche C, Hellmann G, Ranft J.
    Vasa Suppl; 1989 Feb 15; 27():46. PubMed ID: 2623542
    [No Abstract] [Full Text] [Related]

  • 16. [Transcutaneous pO2 and laser Doppler flux in increasing doses of intraarterial and intravenously administered prostaglandin E1].
    Creutzig A, Caspary L, Ranke C, Kiessling D, Wilkens J, Frölich J, Alexander K.
    Vasa; 1987 Feb 15; 16(2):114-8. PubMed ID: 2955602
    [No Abstract] [Full Text] [Related]

  • 17. Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease.
    Edvinsson LI, Edvinsson ML, Angus Deveber G.
    Int Angiol; 2003 Jun 15; 22(2):141-7. PubMed ID: 12865879
    [Abstract] [Full Text] [Related]

  • 18. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
    Joffre F, Meites G, Rousseau H, Staffin C, Allaert FA, Pelat P.
    Ann Radiol (Paris); 1994 Jun 15; 37(3):239-44. PubMed ID: 8092756
    [Abstract] [Full Text] [Related]

  • 19. [Randomized study comparing the clinical effectiveness of intravenous prostaglandin E1 and intravenous pentoxifylline in patients with Fontaine stage IIb arterial occlusive disease].
    Hepp W, von Bary S, Corovic D, Diehm C, Mühe E, Rudofsky G, Scheffler P, Trübestein G, Vogelpohl M.
    Vasa Suppl; 1991 Jun 15; 33():348-9. PubMed ID: 1788753
    [No Abstract] [Full Text] [Related]

  • 20. [Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease].
    Hesse WH, Rudofsky G, Peskar BA.
    Wien Klin Wochenschr; 1991 Jun 15; 103(18):554-7. PubMed ID: 1750222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.